• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by AirSculpt Technologies Inc.

    2/11/22 5:27:11 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care
    Get the next $AIRS alert in real time by email
    SC 13G 1 tm225315d2_sc13g.htm SC 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

     

     

    SCHEDULE 13G

     

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (AMENDMENT NO. )

     

    AIRSCULPT TECHNOLOGIES, INC.
    (Name of Issuer)

     

    Common Stock, $0.001 par value per share
    (Title of Class of Securities)

     

    009496100
    (CUSIP Number)

     

    December 31, 2021
    (Date of Event Which Requires Filing of This Statement)

     

    Check the Appropriate box to designate the rule pursuant to which this schedule is filed:

     

    ¨ Rule 13d-1(b)

    ¨ Rule 13d-1(c)

    x Rule 13d-1(d)

     

    The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

    1 NAME OF REPORTING PERSONS    
      Adam T. Feinstein    
               
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨
            (b) ¨
               
    3 SEC USE ONLY      
               
    4 CITIZENSHIP OR PLACE OF ORGANIZATION    
      United States    
               
      5 SOLE VOTING POWER    
    NUMBER OF   0    
    SHARES 6 SHARED VOTING POWER    
    BENEFICIALLY   29,324,180(1)    
    OWNED BY 7 SOLE DISPOSITIVE POWER    
    EACH   0    
    REPORTING 8 SHARED DISPOSITIVE POWER    

    PERSON WITH

     

     

      29,324,180(1)    
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
      29,324,180(1)      
         
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ¨
           
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9    
      52.70%(2)      
           
    12 TYPE OF REPORTING PERSON*    
      IN        
               
                   

    (1) Consists of 13,575,862 shares of Common Stock held directly by VSCP EBS Aggregator, L.P., a Delaware limited partnership, 4,374,714 shares of Common Stock held directly by Vesey Street Capital Partners Healthcare Fund-A, L.P., a Delaware limited partnership, and 11,373,604 shares of Common Stock held directly by EBS Aggregator Blocker Holdings, LLC, a Delaware limited liability company. Mr. Feinstein serves as managing partner of Vesey Street Capital Partners, L.L.C., a Delaware limited liability company, which is the general partner of Vesey Street Capital Partners Healthcare GP, L.P., a Delaware limited partnership, which serves as the general partner of VSCP EBS Aggregator, L.P. and Vesey Street Capital Partners Healthcare Fund-A, L.P. and the manager of EBS Aggregator Blocker Holdings, LLC.

     

    (2) This percentage is calculated based on 55,640,154 shares of Common Stock outstanding as of December 2, 2021.

     

     

     

     

    1 NAME OF REPORTING PERSONS    
      VSCP EBS Aggregator, L.P.    
               
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨
            (b) ¨
               
    3 SEC USE ONLY      
               
    4 CITIZENSHIP OR PLACE OF ORGANIZATION    
      Delaware    
               
      5 SOLE VOTING POWER    
    NUMBER OF   0    
    SHARES 6 SHARED VOTING POWER    
    BENEFICIALLY   13,575,862(1)    
    OWNED BY 7 SOLE DISPOSITIVE POWER    
    EACH   0    
    REPORTING 8 SHARED DISPOSITIVE POWER    

    PERSON WITH

     

     

      13,575,862(1)    
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
      13,575,862(1)      
         
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ¨
           
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9    
      24.40%(2)      
           
    12 TYPE OF REPORTING PERSON*    
      PN        
               
                   

    (1) Consists of 13,575,862 shares of Common Stock held directly by VSCP EBS Aggregator, L.P.

     

    (2) This percentage is calculated based on 55,640,154 shares of Common Stock outstanding as of December 2, 2021.

     

     

     

     

    1 NAME OF REPORTING PERSONS    
      Vesey Street Capital Partners Healthcare Fund-A, L.P.    
               
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨
            (b) ¨
               
    3 SEC USE ONLY      
               
    4 CITIZENSHIP OR PLACE OF ORGANIZATION    
      Delaware    
               
      5 SOLE VOTING POWER    
    NUMBER OF   0    
    SHARES 6 SHARED VOTING POWER    
    BENEFICIALLY   4,374,714(1)    
    OWNED BY 7 SOLE DISPOSITIVE POWER    
    EACH   0    
    REPORTING 8 SHARED DISPOSITIVE POWER    

    PERSON WITH

     

     

      4,374,714(1)    
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
      4,374,714(1)      
         
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ¨
           
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9    
      7.86%(2)      
           
    12 TYPE OF REPORTING PERSON*    
      PN        
               
                   

    (1) Consists of 4,374,714 shares of Common Stock held directly by Vesey Street Capital Partners Healthcare Fund-A, L.P.

     

    (2) This percentage is calculated based on 55,640,154 shares of Common Stock outstanding as of December 2, 2021.

     

     

     

     

    1 NAME OF REPORTING PERSONS    
      EBS Aggregator Blocker Holdings, LLC    
               
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨
            (b) ¨
               
    3 SEC USE ONLY      
               
    4 CITIZENSHIP OR PLACE OF ORGANIZATION    
      Delaware    
               
      5 SOLE VOTING POWER    
    NUMBER OF   0    
    SHARES 6 SHARED VOTING POWER    
    BENEFICIALLY   11,373,604(1)    
    OWNED BY 7 SOLE DISPOSITIVE POWER    
    EACH   0    
    REPORTING 8 SHARED DISPOSITIVE POWER    

    PERSON WITH

     

     

      11,373,604(1)    
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
      11,373,604(1)      
         
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ¨
           
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9    
      20.44%(2)      
           
    12 TYPE OF REPORTING PERSON*    
      CO        
               
                   

    (1) Consists of 11,373,604 shares of Common Stock held directly by EBS Aggregator Blocker Holdings, LLC.

     

    (2) This percentage is calculated based on 55,640,154 shares of Common Stock outstanding as of December 2, 2021.

     

     

     

     

    1 NAME OF REPORTING PERSONS    
      Vesey Street Capital Partners, L.L.C.    
               
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨
            (b) ¨
               
    3 SEC USE ONLY      
               
    4 CITIZENSHIP OR PLACE OF ORGANIZATION    
      Delaware    
               
      5 SOLE VOTING POWER    
    NUMBER OF   0    
    SHARES 6 SHARED VOTING POWER    
    BENEFICIALLY   29,324,180(1)    
    OWNED BY 7 SOLE DISPOSITIVE POWER    
    EACH   0    
    REPORTING 8 SHARED DISPOSITIVE POWER    

    PERSON WITH

     

     

      29,324,180(1)    
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
      29,324,180(1)      
         
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ¨
           
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9    
      52.70%(2)      
           
    12 TYPE OF REPORTING PERSON*    
      CO        
               
                   

    (1) Consists of 13,575,862 shares of Common Stock held directly by VSCP EBS Aggregator, L.P., a Delaware limited partnership, 4,374,714 shares of Common Stock held directly by Vesey Street Capital Partners Healthcare Fund-A, L.P., a Delaware limited partnership, and 11,373,604 shares of Common Stock held directly by EBS Aggregator Blocker Holdings, LLC, a Delaware limited liability company. Mr. Feinstein serves as managing partner of Vesey Street Capital Partners, L.L.C., a Delaware limited liability company, which is the general partner of Vesey Street Capital Partners Healthcare GP, L.P., a Delaware limited partnership, which serves as the general partner of VSCP EBS Aggregator, L.P. and Vesey Street Capital Partners Healthcare Fund-A, L.P. and the manager of EBS Aggregator Blocker Holdings, LLC.

     

    (2) This percentage is calculated based on 55,640,154 shares of Common Stock outstanding as of December 2, 2021.

     

     

     

     

    Item 1 (a). Name of Issuer:

     

    AirSculpt Technologies, Inc.

     

    Item 1 (b). Address of Issuer's Principal Executive Offices:

     

    c/o AirSculpt Technologies, Inc.

    400 Alton Road, Unit TH-103M

    Miami Beach, Florida

     

    Item 2 (a). Name of Persons Filing:

     

    The persons filing this statement are Adam T. Feinstein, VSCP EBS Aggregator, L.P., Vesey Street Capital Partners Healthcare Fund-A, L.P., EBS Aggregator Blocker Holdings, LLC, and Vesey Street Capital Partners, L.L.C. Together, Adam T. Feinstein, VSCP EBS Aggregator, L.P., Vesey Street Capital Partners Healthcare Fund-A, L.P., EBS Aggregator Blocker Holdings, LLC, and Vesey Street Capital Partners, L.L.C. are the “Reporting Persons.”

     

    Item 2 (b). Address of Principal Business Office or, if None, Residence:

     

    c/o AirSculpt Technologies, Inc.

    400 Alton Road, Unit TH-103M

    Miami Beach, Florida

     

    Item 2 (c). Citizenship:

     

    Adam T. Feinstein is a United States citizen.

    VSCP EBS Aggregator, L.P. is a Delaware limited partnership.

    Vesey Street Capital Partners Healthcare Fund-A, L.P. is a Delaware limited partnership.

    EBS Aggregator Blocker Holdings, LLC is a Delaware limited liability company.

    Vesey Street Capital Partners, L.L.C. is a Delaware limited liability company.

     

    Item 2 (d). Title of Class of Securities:

     

    Common Stock, $0.001 par value per share.

     

    Item 2 (e). CUSIP Number:

     

    009496100

     

    Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

     

    (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

     

    (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

     

    (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

     

    (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

     

    (e) ¨ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

     

    (f) ¨ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

     

    (g) ¨ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

     

    (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

     

     

     

    (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3):

     

    (j) ¨ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);

     

    (k) ¨ Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

     

    If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: __

     

    Item 4. Ownership.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities identified in Item 1.

     

    Adam T. Feinstein

     

    (a) Amount beneficially owned: 29,324,180

     

    (b) Percent of class: 52.70%

     

    (c) Number of shares as to which such person has:

     

    (i) Sole power to vote or to direct the vote: 0

     

    (ii) Shared power to vote or to direct the vote: 29,324,180

     

    (iii) Sole power to dispose or to direct the disposition of: 0

     

    (iv) Shared power to dispose or to direct the disposition of: 29,324,180

     

    VSCP EBS Aggregator, L.P.

     

    (a) Amount beneficially owned: 13,575,862

     

    (b) Percent of class: 24.40%

     

    (c) Number of shares as to which such person has:

     

    (i) Sole power to vote or to direct the vote: 0

     

    (ii) Shared power to vote or to direct the vote: 13,575,862

     

    (iii) Sole power to dispose or to direct the disposition of: 0

     

    (iv) Shared power to dispose or to direct the disposition of: 13,575,862

     

     

     

     

    Vesey Street Capital Partners Healthcare Fund-A, L.P.

     

    (a) Amount beneficially owned: 4,374,714

     

    (b) Percent of class: 7.86%

     

    (c) Number of shares as to which such person has:

     

    (i) Sole power to vote or to direct the vote: 0

     

    (ii) Shared power to vote or to direct the vote: 4,374,714

     

    (iii) Sole power to dispose or to direct the disposition of: 0

     

    (iv) Shared power to dispose or to direct the disposition of: 4,374,714

     

    EBS Aggregator Blocker Holdings, LLC

     

    (a) Amount beneficially owned: 11,373,604

     

    (b) Percent of class: 20.44%

     

    (c) Number of shares as to which such person has:

     

    (i) Sole power to vote or to direct the vote: 0

     

    (ii) Shared power to vote or to direct the vote: 11,373,604

     

    (iii) Sole power to dispose or to direct the disposition of: 0

     

    (iv) Shared power to dispose or to direct the disposition of: 11,373,604

     

    Vesey Street Capital Partners, L.L.C.

     

    (a) Amount beneficially owned: 29,324,180

     

    (b) Percent of class: 52.70%

     

    (c) Number of shares as to which such person has:

     

    (i) Sole power to vote or to direct the vote: 0

     

    (ii) Shared power to vote or to direct the vote: 29,324,180

     

    (iii) Sole power to dispose or to direct the disposition of: 0

     

    (iv) Shared power to dispose or to direct the disposition of: 29,324,180

     

     

     

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If the statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.

     

    N/A

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    Mr. Feinstein may be deemed to beneficially own, and have voting and dispositive power over, the shares of Common Stock held by VSCP EBS Aggregator, L.P., EBS Aggregator Blocker Holdings, LLC, and Vesey Street Capital Partners Healthcare Fund-A, L.P. through his role as managing partner of Vesey Street Capital Partners, L.L.C., which serves as the general partner of Vesey Street Capital Partners Healthcare GP, L.P., which serves as general partner or manager of each of the entities holding Common Stock. Each of the Reporting Persons disclaims beneficial ownership of any securities that exceed its pecuniary interest therein.

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

     

    N/A

     

    Item 8. Identification and Classification of Members of the Group.

     

    N/A

     

    Item 9. Notice of Dissolution of Group.

     

    N/A

     

    Item 10. Certification. 

     

    N/A

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    February 11, 2022

     

      By: /s/ Adam T. Feinstein
        Adam T. Feinstein
         
      VSCP EBS AGGREGATOR, L.P.
         
      By: /s/ Adam T. Feinstein
        Adam T. Feinstein
        Authorized Signatory
       
      VESEY STREET CAPITAL PARTNERS HEALTHCARE FUND-A, L.P.
         
      By: /s/ Adam T. Feinstein
        Adam T. Feinstein
        Authorized Signatory
       
      EBS AGGREGATOR BLOCKER HOLDINGS, LLC
         
      By: /s/ Adam T. Feinstein
        Adam T. Feinstein
        Authorized Signatory
         
      VESEY STREET CAPITAL PARTNERS, L.L.C.
         
      By: /s/ Adam T. Feinstein
        Adam T. Feinstein
        Authorized Signatory

     

     

     

     

    EXHIBIT INDEX

     

    Exhibit   Description of Exhibit
       
    99.1   Joint Filing Agreement (filed herewith)

     

     

     

    Get the next $AIRS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIRS

    DatePrice TargetRatingAnalyst
    10/17/2024Neutral
    BTIG Research
    5/14/2024$8.25 → $5.00Outperform → Market Perform
    Leerink Partners
    11/11/2022$4.00Overweight → Neutral
    Piper Sandler
    6/16/2022$17.00 → $8.50Overweight → Equal-Weight
    Morgan Stanley
    11/23/2021$18.00Outperform
    Raymond James
    11/23/2021$17.00Overweight
    Morgan Stanley
    11/23/2021$26.00Outperform
    SVB Leerink
    11/23/2021$22.00Overweight
    Piper Sandler
    More analyst ratings

    $AIRS
    SEC Filings

    View All

    SEC Form 10-Q filed by AirSculpt Technologies Inc.

    10-Q - Airsculpt Technologies, Inc. (0001870940) (Filer)

    8/1/25 3:43:27 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)

    8/1/25 3:38:52 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)

    8/1/25 6:06:52 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $AIRS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AirSculpt Technologies Announces Participation in Sidoti Micro Cap Conference

    MIAMI BEACH, Fla., Aug. 13, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced that the Company will participate in the Sidoti Micro Cap Conference being held virtually from August 20 to 21, 2025. Management will meet with investors throughout both days and host a presentation at 10:00am ET on Wednesday, August 20. The presentation will be webcast live at https://investors.airsculpt.com. An archive of the webcast presentation will be available for 90 days. About AirSculpt AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and

    8/13/25 6:00:00 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies Reports Second Quarter Fiscal 2025 Results

    MIAMI BEACH, Fla., Aug. 01, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the second quarter ended June 30, 2025. The Company also announced that Dennis Dean intends to retire from his position of Chief Financial Officer. Mr. Dean will retain his role until a permanent successor is in place. Yogi Jashnani, Chief Executive Officer, stated: "In an ongoing dynamic environment, the second quarter saw us advance our transformation initiatives, and based on our results and our outlook, we remain on track to achieve our annual guidance. We narrowed our year-

    8/1/25 6:00:00 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies Announces Second Quarter Fiscal 2025 Earnings Release Date and Conference Call

    MIAMI BEACH, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS), an industry leader and provider of premium body contouring procedures, today announced it will report second quarter 2025 financial results before market open on Friday, August 1, 2025, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13754561 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the Air

    7/25/25 6:45:00 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $AIRS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on AirSculpt Technologies

    BTIG Research initiated coverage of AirSculpt Technologies with a rating of Neutral

    10/17/24 7:13:51 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies downgraded by Leerink Partners with a new price target

    Leerink Partners downgraded AirSculpt Technologies from Outperform to Market Perform and set a new price target of $5.00 from $8.25 previously

    5/14/24 7:53:44 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded AirSculpt Technologies from Overweight to Neutral and set a new price target of $4.00

    11/11/22 3:44:11 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $AIRS
    Financials

    Live finance-specific insights

    View All

    AirSculpt Technologies Announces Second Quarter Fiscal 2025 Earnings Release Date and Conference Call

    MIAMI BEACH, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS), an industry leader and provider of premium body contouring procedures, today announced it will report second quarter 2025 financial results before market open on Friday, August 1, 2025, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13754561 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the Air

    7/25/25 6:45:00 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance

    MIAMI BEACH, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2025. "We began the year reporting results in line with our expectations, and while we are early in our transformation, I am encouraged by the progress the team has made on the business imperatives we set in place at the start of the year and I remain confident that we have identified and are implementing the right actions to return to growth," stated Yogi Jashnani, Chief Executive Officer. "To this end, the first quarter saw profitability

    5/2/25 6:00:00 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies Announces First Quarter Fiscal 2025 Earnings Release Date and Conference Call

    MIAMI BEACH, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report first quarter 2025 financial results before market open on Friday, May 2, 2025, to be followed by a conference call on the same day at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13753206 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirScul

    4/25/25 6:45:00 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $AIRS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by AirSculpt Technologies Inc.

    SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)

    11/8/24 8:42:05 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by AirSculpt Technologies Inc. (Amendment)

    SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)

    2/14/24 1:11:48 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by AirSculpt Technologies Inc.

    SC 13G - Airsculpt Technologies, Inc. (0001870940) (Subject)

    4/27/23 9:49:49 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $AIRS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Feinstein Adam T bought $4,000,000 worth of shares (1,000,000 units at $4.00) (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    6/11/25 5:06:44 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    Executive Chairman Rollins Aaron bought $7,629 worth of shares (2,118 units at $3.60), increasing direct ownership by 0.01% to 15,146,039 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    5/20/25 4:11:19 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    Director Chu Caroline was granted 58,594 shares, increasing direct ownership by 50% to 176,780 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    5/8/25 7:55:44 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $AIRS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Feinstein Adam T bought $4,000,000 worth of shares (1,000,000 units at $4.00) (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    6/11/25 5:06:44 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    Executive Chairman Rollins Aaron bought $7,629 worth of shares (2,118 units at $3.60), increasing direct ownership by 0.01% to 15,146,039 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    5/20/25 4:11:19 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    Chief Executive Officer Jashnani Yogesh bought $18,532 worth of shares (7,000 units at $2.65), increasing direct ownership by 2% to 464,879 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    5/7/25 5:56:15 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $AIRS
    Leadership Updates

    Live Leadership Updates

    View All

    AirSculpt Technologies Names Yogi Jashnani Chief Executive Officer

    MIAMI BEACH, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), an industry leader and provider of premium body contouring procedures, today announced the appointment of Yogi Jashnani as Chief Executive Officer ("CEO") and a member of the Board of Directors. He succeeds Dennis Dean, Interim Chief Executive Officer and Chief Financial Officer who will continue as Chief Financial Officer, all effective January 7, 2025. A highly-talented, results oriented executive with an accomplished career spanning more than two decades, Mr. Jashnani has architected successful transformations for public and private companies in the aesthetics

    12/17/24 6:45:00 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care